# Differential Expression of Antioxidant and Oxidant Pathways in Chronic Rhinosinusitis Without Nasal Polyps

**Authors:** Yih-Jeng Tsai, Jiunn-Min Shieh, Ming-Chieh Ma, Wen-Bin Wu

PMC · DOI: 10.3390/antiox14111292 · 2025-10-28

## TL;DR

This study identifies unique redox gene expression patterns in chronic rhinosinusitis without nasal polyps, showing increased oxidative stress and distinct differences compared to cases with nasal polyps.

## Contribution

The study provides a systematic transcriptomic analysis of redox gene expression in CRSsNP, revealing unique antioxidant and oxidant pathway differences compared to CRSwNP.

## Key findings

- 27 redox genes were differentially expressed in CRSsNP, with 24 upregulated and 3 downregulated.
- CRSsNP showed a significant increase in oxidative stress compared to controls.
- CRSsNP and CRSwNP had 16 unique redox differentially expressed genes, indicating distinct pathophysiological mechanisms.

## Abstract

Chronic rhinosinusitis without nasal polyps (CRSsNP) is a chronic inflammatory disease that lacks a clear pathogenesis/pathophysiology. While large studies focused on elucidating the pathophysiology of CRS with NPs (CRSwNP), this study aimed to use a systemic evaluation approach to identify the redox gene expression profile, its association with oxidative damage in CRSsNP, and the differences between CRSsNP and -wNP. The expression of 84 redox genes was analyzed using real-time PCR array in control and CRSsNP nasal mucosae. Changes in the mRNA and protein levels of these redox differentially expressed genes (DEGs) were verified using a customized real-time PCR array, RT-PCR, and Western blotting in an additional 18 patients. 4-Hydroxynonenal (lipid peroxidation) and 3-nitrotyrosine (protein nitrosylation) expression, representing oxidative stress (OxS) and nitrosative stress (NsS) status, were examined using immunohistochemistry. We found 27 DEGs (24 upregulated and 3 downregulated) in CRSsNP. AKR1C2, GCLM, GPX2, NOS2, and NQO1 were upregulated and LPO was downregulated more than 4-fold. These changes led to a substantial increase in OxS in CRSsNP nasal mucosa. In a comparison of the currently identified 27 DEGs with the 23 previously reported CRSwNP genes, there were 16 unique redox DEGs expressed between CRSsNP and -wNP. A String protein interaction network analysis revealed that CRSsNP possessed “an adaptive antioxidant defense signature”, while CRSwNP showed “a pro-inflammatory and -oxidant pathway”. Collectively, we systemically performed transcriptomic analysis to profile OxS-related genes in CRSsNP and highlighted the unique redox gene sets and pathway differences between CRSsNP and -wNP.

## Linked entities

- **Genes:** AKR1C2 (aldo-keto reductase family 1 member C2) [NCBI Gene 1646], GCLM (glutamate-cysteine ligase modifier subunit) [NCBI Gene 2730], GPX2 (glutathione peroxidase 2) [NCBI Gene 2877], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843], NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728], LPO (lactoperoxidase) [NCBI Gene 4025]

## Full-text entities

- **Genes:** NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, GCLM (glutamate-cysteine ligase modifier subunit) [NCBI Gene 2730] {aka GLCLR}, AKR1C2 (aldo-keto reductase family 1 member C2) [NCBI Gene 1646] {aka AKR1C-pseudo, BABP, DD, DD-2, DD/BABP, DD2}, GPX2 (glutathione peroxidase 2) [NCBI Gene 2877] {aka GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI}
- **Diseases:** inflammatory (MESH:D007249), CRSsNP (MESH:D009298), CRS (MESH:D003398)
- **Chemicals:** lipid (MESH:D008055), 4-Hydroxynonenal (MESH:C027576), 3-nitrotyrosine (MESH:C002744), LPO (MESH:D008054)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12649171/full.md

---
Source: https://tomesphere.com/paper/PMC12649171